Conceptual foundations of pharmacoeconomic analysis of prevention technologies of chronic viral infections
Journal Title: Фармацевтичний журнал - Year 2019, Vol 5, Issue 5
Abstract
The introduction of various technologies for the prevention of chronic viral infections into practice requires well-founded evidence of their effectiveness, which can be obtained using pharmacoeconomic methods and models that determine not only the effectiveness and feasibility of introducing preventive technologies, but also the socio-economic associated consequences. In this context, the development of a unified model for the pharmacoeconomic evaluation of medical technologies at all stages of the prevention of chronic viral infections is key to implementing optimal strategies for combating them for both individual groups and the entire population, developing recommendations for the rational use of diagnostic tests and viral vaccines, and determining the optimal level of pharmaceutical care for patients. The aim of the work – development of a conceptual model of pharmacoeconomic analysis of technologies for the prevention of chronic viral infections. Pharmacoeconomic evaluation of technologies for the prevention of chronic viral infections is possible on the basis of an analytical platform that determines the relationship between the target population to be prevented, and the effectiveness of intermediate and final results. The pharmacoeconomic analysis of technologies for the prevention of socially significant chronic viral infections was proposed to be carried out according to the developed algorithm. Implementation of the proposed algorithm for pharmacoeconomic analysis of various technologies for the prevention of chronic viral infections was based on developed unified model of the spread of viral infection in the population, where individuals can be assigned to different clinical and epidemiological classes. This model was a combination of epidemiological and clinical prognostic approaches and can be used to predict and conduct pharmacoeconomic assessment of viral infection prevention technologies with a general decrease in the number of people in a particular epidemiological class when applying medical technology for a certain period of time. The presented concept allows to formulate the principles of pharmacoeconomic evaluation of technologies for the prevention of chronic viral infections. It was advisable to use the concept of quality of life in assessing the usefulness of the technologies under study, which allows to formalize the cost-utility coefficient, minimization of which determines pharmacoeconomic reasonable strategies for the prevention of chronic viral infections. The developed concept is promising, and information technologies based on it can become a reliable source of information to support decision-making by health experts in the pharmacoeconomic evaluation of technologies for the prevention of chronic viral infections.
Authors and Affiliations
S. O. Soloviov, I. V. Dziublyk, V. V. Trokhymchuk
Keywords
Related Articles
- EP ID EP671109
- DOI 10.32352/0367-3057.5.19.04
- Views 78
- Downloads 0
Motivation of obtaining higher pharmaceutical education of students of the National Pharmaceutical University
Choice of profession is the main factor in the further life of man, his attitude to himself and the world. When choosing a profession, a person is guided by a number of motives. In modern society, the motives of high sc...
Pharmaceutical development with commercialization of generic drugs with poor soluble substance – tablets of drug nimodipine
The pharmaceutical development of solid dosage forms which containing a poor soluble substance deserves special attention, because a composition and a technology of production such drugs directly effects on release the a...
Development of techniques to identify and determine the active ingredient in dental gel composition
The technique of the qualitative and quantitative determination of active substances – decamethoxine and lidocaine hydrochloride in a new combination drug for preventing and treating inflammatory diseases of the oral cav...
Experimental rationale of selection of the hypoglicemic dose of ginger dry extract on normoglycemic rats
Modern regimens for treatment of type 2 diabetes include various groups of oral hypoglycemic agents, most of which could cause side effects. Pharmacological activity of these medicines with long-term use is often reduced...
Evaluation of factions antigens disintegration fungal cells Candida albicans and Candida tropicalis if advised candidiasis
Candidiasis – one of the most common fungal diseases humanity has ever faced. Etiological factors of the disease are most often Candida albicans and Candida tropicalis. To fight Candida infection has been actively conduc...